<DOC>
	<DOCNO>NCT02281669</DOCNO>
	<brief_summary>Cutaneous leishmaniasis ( CL ) endemic Israel cause Leishmania major Leishmania tropica . CL usually benign disease limit skin . One local treatment available intralesional ( IL ) Pentostam injection . During current study investigator monitor adverse effect treatment follow recovery lesion Pentostam injection .</brief_summary>
	<brief_title>Prospective Observational Study Intralesional Treatment With Pentostam Cutaneous Leishmaniasis Israeli Patients</brief_title>
	<detailed_description>Cutaneous leishmaniasis usually treat topical intervention . In severe case intralesional Pentostam injection may apply . This treatment extremely efficient painful , however without know adverse effect IV Pentostam treatment . In study investigator follow systematically leishmania patient receive intralesional treatment . A structured questionnaire fill doctor visit . The current study goal examine adverse effect patient reaction treatment , follow recovery lesion ( ) treatment include number IL injection need .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Cutaneous</mesh_term>
	<mesh_term>Antimony Sodium Gluconate</mesh_term>
	<criteria>Cutaneous leishmaniasis patient Treatment IL Pentostam Age 18 year Children pregnant woman participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>